- Jan 18, 2001
- 3,224
- 1,084
- 113
- School/Org
- ODwire
- City
- Lansdale
- State
- PA
GENEVA, February 24, 2025 – Alcon (SIX/NYSE: ALC) today announced the U.S. launch of Systane® Pro Preservative-Free (PF) as the latest over-the-counter eye drop in the company’s dry eye portfolio. Systane Pro PF is the longest lasting eye drop in the Systane portfolio with a unique triple action, preservative-free formula for the temporary relief of burning and irritation due to dryness of the eye.1
Dry eye disease is one of the most common ocular surface disorders, affecting an estimated 45.5 million people in the United States and 1.5 billion globally.2 Developed exclusively to offer dry eye symptom relief, Systane Pro PF is a one-of-a-kind formula that works to provide sustained hydration, restore tear film stability and protect against further irritation of dry eyes.
“We are proud to introduce Systane Pro PF, the first and only multi-dose preservative-free triple action formula with hyaluronate, nano-sized lipids and HP-Guar that support the active ingredient giving patients long-lasting relief from the symptoms of dry eye,” said Terry Kim, MD, chief medical officer and head of global medical safety, Alcon. “This is another example of how Alcon is bringing innovation to the Systane portfolio to address the needs of dry eye patients.”
Patients with dry eyes often experience symptoms when moisture retention and tear stability are impacted by a variety of factors including aging, environment and digital device use.3 The unique formulation of Systane Pro PF works to deliver long-lasting dry eye symptom relief for all types of dry eyes.1
“As an eye care professional and global dry eye expert, I know that patients should benefit from the design of a triple action preservative-free formula that includes hyaluronate to address all types of dry eye,” said Dr. Selina McGee, founder and chief optometrist of Bespoke Vision in Edmond, OK. “Systane Pro PF provides hydration and protection of the ocular surface and can also stabilize the lipid layer of the tear film to reduce evaporation and provide lasting dry eye relief for my patients.”
References
1. Alcon data on file, 2025.
2. Dry Eye Products Markets Report, Market Scope, 2023.
3. Market Scope LLC. 2020 Dry Eye Products Report: A Global Market Analysis for 2019 to 2025. St. Louis, MO.
The launch begins in the U.S. this month and will extend to additional markets in 2026. Systane Pro PF will be featured at the SECO International meeting this week in Atlanta.
Dry eye disease is one of the most common ocular surface disorders, affecting an estimated 45.5 million people in the United States and 1.5 billion globally.2 Developed exclusively to offer dry eye symptom relief, Systane Pro PF is a one-of-a-kind formula that works to provide sustained hydration, restore tear film stability and protect against further irritation of dry eyes.
“We are proud to introduce Systane Pro PF, the first and only multi-dose preservative-free triple action formula with hyaluronate, nano-sized lipids and HP-Guar that support the active ingredient giving patients long-lasting relief from the symptoms of dry eye,” said Terry Kim, MD, chief medical officer and head of global medical safety, Alcon. “This is another example of how Alcon is bringing innovation to the Systane portfolio to address the needs of dry eye patients.”
Patients with dry eyes often experience symptoms when moisture retention and tear stability are impacted by a variety of factors including aging, environment and digital device use.3 The unique formulation of Systane Pro PF works to deliver long-lasting dry eye symptom relief for all types of dry eyes.1
“As an eye care professional and global dry eye expert, I know that patients should benefit from the design of a triple action preservative-free formula that includes hyaluronate to address all types of dry eye,” said Dr. Selina McGee, founder and chief optometrist of Bespoke Vision in Edmond, OK. “Systane Pro PF provides hydration and protection of the ocular surface and can also stabilize the lipid layer of the tear film to reduce evaporation and provide lasting dry eye relief for my patients.”
References
1. Alcon data on file, 2025.
2. Dry Eye Products Markets Report, Market Scope, 2023.
3. Market Scope LLC. 2020 Dry Eye Products Report: A Global Market Analysis for 2019 to 2025. St. Louis, MO.
The launch begins in the U.S. this month and will extend to additional markets in 2026. Systane Pro PF will be featured at the SECO International meeting this week in Atlanta.
